Aspen Aerogels Secures PyroThin Contract Amid Q1 Loss

Aspen Aerogels ( (ASPN) ) has provided an announcement.

Aspen Aerogels reported a first-quarter 2025 revenue of $78.7 million, down from $94.5 million in the same period last year, and a net loss of $301.2 million, largely due to a $286.6 million impairment charge related to the demobilization of a planned manufacturing plant. Despite these challenges, the company secured a PyroThin contract with a leading American OEM for a future vehicle platform, showcasing its strategic focus on expanding its thermal barrier and energy industrial segments, optimizing costs, and strengthening its supply chain.

Spark’s Take on ASPN Stock

According to Spark, TipRanks’ AI Analyst, ASPN is a Neutral.

Aspen Aerogels’ overall score reflects strong financial improvements and operational efficiency, offset by high valuation and technical pressures. The earnings call acknowledged key growth drivers but also highlighted potential challenges such as halted expansion and tariff risks. While the company shows promise, the stock’s current technical and valuation metrics suggest a cautious approach.

To see Spark’s full report on ASPN stock, click here.

More about Aspen Aerogels

Aspen Aerogels, Inc. is a technology leader in sustainability and electrification solutions, focusing on aerogel technology to enhance resource efficiency, e-mobility, and clean energy. Their PyroThin products address thermal runaway challenges in the electric vehicle market, while their carbon aerogel initiative aims to improve lithium-ion battery performance.

Average Trading Volume: 2,001,060

Technical Sentiment Signal: Sell

Current Market Cap: $451.6M

Find detailed analytics on ASPN stock on TipRanks’ Stock Analysis page.